DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+13.79%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.38B
AUM Growth
+$2.38B
(-6.9%)
Cap. Flow
-$217M
Cap. Flow
% of AUM
-9.13%
Top 10 Holdings %
Top 10 Hldgs %
36.37%
Holding
147
New
12
Increased
26
Reduced
28
Closed
38
Top Buys
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$41.3M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$37.9M |
| 3 |
ELGX
Endologix Inc
ELGX
|
$28.8M |
| 4 |
Pacira BioSciences
PCRX
|
$25.5M |
| 5 |
GSK
GSK
|
$24.5M |
Sector Composition
| 1 | Healthcare | 70.92% |
| 2 | Financials | 4.5% |
| 3 | Technology | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GHDX
26
DELISTED
Genomic Health, Inc.
GHDX
| $28.5M | 1.15% |
809,432
-284,084
| -26% | -$10M |
|
|
27
Pacira BioSciences
PCRX
$1.22B
| $28.5M | 1.15% |
371,000
-331,485
| -47% | -$25.5M |
|
|
FPRX
28
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $28.2M | 1.14% |
+680,000
| New | +$28.2M |
|
29
Zevra Therapeutics
ZVRA
$501M
| $28.2M | 1.14% |
1,420,497
| – | – |
|
|
SRRA
30
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $26.9M | 1.09% |
1,791,255
+442,854
| +33% | +$6.66M |
|
|
RLYP
31
DELISTED
RELYPSA INC COM
RLYP
| $25.5M | 1.03% |
900,281
-200,719
| -18% | -$5.69M |
|
|
GWPH
32
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $21.5M | 0.87% |
310,122
-81,000
| -21% | -$5.62M |
|
33
CytomX Therapeutics
CTMX
$350M
| $19.7M | 0.8% |
+946,022
| New | +$19.7M |
|
|
AERI
34
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $19.7M | 0.8% |
807,875
| – | – |
|
35
Protara Therapeutics
TARA
$125M
| $19.6M | 0.8% |
1,265,343
| – | – |
|
|
RAD
36
DELISTED
Rite Aid Corporation
RAD
| $19.5M | 0.79% |
2,492,772
-1,730,028
| -41% | -$13.6M |
|
37
Regenxbio
RGNX
$498M
| $19.4M | 0.79% |
1,169,042
-167,500
| -13% | -$2.78M |
|
38
Xencor
XNCR
$594M
| $18.4M | 0.74% |
1,256,612
-530,388
| -30% | -$7.75M |
|
39
Pacific Biosciences
PACB
$378M
| $18.2M | 0.74% |
1,388,000
-797,771
| -36% | -$10.5M |
|
|
ACHN
40
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $18M | 0.73% |
1,667,000
| – | – |
|
41
Axogen
AXGN
$718M
| $16.9M | 0.69% |
3,381,439
| – | – |
|
|
DBVT
42
DBV Technologies
DBVT
$249M
| $16.8M | 0.68% |
461,869
| – | – |
|
|
AKTX
43
Akari Therapeutics
AKTX
$21.4M
| $16.7M | 0.68% |
1,150,700
| – | – |
|
44
Centene
CNC
$14.8B
| $16.1M | 0.65% |
+244,000
| New | +$16.1M |
|
45
MacroGenics
MGNX
$121M
| $16M | 0.65% |
517,920
-39,080
| -7% | -$1.21M |
|
|
CSII
46
DELISTED
Cardiovascular Systems, Inc.
CSII
| $15.6M | 0.63% |
+1,035,000
| New | +$15.6M |
|
|
GI
47
DELISTED
EndoChoice Holdings, Inc.
GI
| $15.2M | 0.62% |
1,823,309
+25,600
| +1% | +$214K |
|
|
ALIM
48
DELISTED
Alimera Sciences, Inc.
ALIM
| $14.2M | 0.58% |
5,878,015
+1,457,435
| +33% | +$3.53M |
|
|
IMPR
49
DELISTED
IMPRIVATA, INC COM
IMPR
| $13.6M | 0.55% |
1,206,418
+55,278
| +5% | +$625K |
|
|
NSTG
50
DELISTED
NanoString Technologies, Inc.
NSTG
| $13M | 0.53% |
880,622
| – | – |
|